Health
Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy – DocWire News
PLoS One. 2021 Jan 20;16(1):e0237202. doi: 10.1371/journal.pone.0237202. eCollection 2021.ABSTRACTBACKGROUND: The novel coronavirus (SARS-CoV-2) pandemic
PLoS One. 2021 Jan 20;16(1):e0237202. doi: 10.1371/journal.pone.0237202. eCollection 2021.
ABSTRACT
BACKGROUND: The novel coronavirus (SARS-CoV-2) pandemic spread rapidly worldwide increasing exponentially in Italy. To date, there is lack of studies describing clinical characteristics of the people at high risk of infection. Hence, we aimed (i) to identify clinical predictors of SARS-CoV-2 infection risk, (ii) to develop and validate a score predicting SARS-CoV-2 infection risk, and (iii) to compare…
-
Business18 hours agoWarning! These ASX 200 shares were just downgraded
-
Business11 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business11 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Business16 hours ago2 monthly payers you’ll want to own in 2025 and beyond